Cargando…
Prognostic and Theranostic Applications of Positron Emission Tomography for a Personalized Approach to Metastatic Castration-Resistant Prostate Cancer
Metastatic castration-resistant prostate cancer (mCRPC) represents a condition of progressive disease in spite of androgen deprivation therapy (ADT), with a broad spectrum of manifestations ranging from no symptoms to severe debilitation due to bone or visceral metastatization. The management of mCR...
Autores principales: | Filippi, Luca, Frantellizzi, Viviana, Chiaravalloti, Agostino, Pontico, Mariano, De Feo, Maria Silvia, Corica, Ferdinando, Montebello, Melissa, Schillaci, Orazio, De Vincentis, Giuseppe, Bagni, Oreste |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002334/ https://www.ncbi.nlm.nih.gov/pubmed/33809749 http://dx.doi.org/10.3390/ijms22063036 |
Ejemplares similares
-
Novel Theranostic Approaches Targeting CCR4-Receptor, Current Status and Translational Prospectives: A Systematic Review
por: Gorica, Joana, et al.
Publicado: (2023) -
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
por: Sidrak, Marko Magdi Abdou, et al.
Publicado: (2023) -
DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review
por: Filippi, Luca, et al.
Publicado: (2022) -
Prognostic Value of (18)F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
por: Filippi, Luca, et al.
Publicado: (2020) -
Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review
por: Conte, Miriam, et al.
Publicado: (2023)